Ravina Bernard 4
4 · Praxis Precision Medicines, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Ravina Bernard
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-07+22,000→ 102,533 total - Award
Stock Option (Right to Buy)
2022-01-07+77,000→ 77,000 totalExercise: $18.11Exp: 2032-01-07→ Common Stock (77,000 underlying)
Footnotes (2)
- [F1]Dr. Ravina was awarded 22,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.